GlassScriptPhysician profile
Hina Kouser
NPI 1114977964
$2,798.38
in general payments reported to CMS, 2019-2025
25 companies · $496 in 2025
The $496 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $204 · 2021: $758 · 2022: $528 · 2023: $237 · 2024: $136 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $869.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,015.99 | 2019-2023 | |
| Amgen INC. | $396.55 | 2019-2025 | Evenity, Prolia, Uplizna |
| Janssen Biotech, INC. | $306.53 | 2019-2025 | Tremfya |
| Astellas Pharma US INC | $184.99 | 2021 | |
| Radius Health, INC. | $167.85 | 2021-2025 | Tymlos |
| E.R. Squibb & Sons, L.L.C. | $163.65 | 2022-2023 | Orencia |
| Mallinckrodt Hospital Products INC. | $69.09 | 2021-2025 | Acthar |
| Axsome Therapeutics, INC. | $49.35 | 2023-2025 | Sunosi |
| Tg Therapeutics, INC. | $46.15 | 2024 | |
| Inspire Medical Systems, INC. | $43.26 | 2025 | Inspire |
| Ucb, INC. | $41.70 | 2020-2022 | |
| Zoll Respicardia, INC. | $37.24 | 2024 | Remede System |
| Regeneron Healthcare Solutions, INC. | $34.52 | 2019-2020 | |
| Exact Sciences Corporation | $32.84 | 2024 | Cologuard Collection Kit |
| Harmony Biosciences LLC | $28.99 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.91 | 2025 | Ofev |
| Celgene Corporation | $24.88 | 2019 | |
| Idorsia Pharmaceuticals US INC | $19.87 | 2024 | Quviviq |
| Astrazeneca Pharmaceuticals LP | $18.46 | 2025 | |
| Alexion Pharmaceuticals, INC. | $17.66 | 2019 | |
| Sobi, INC | $15.42 | 2019 | |
| Medtronic, INC. | $15.18 | 2021 | |
| Zyla Life Sciences, INC. | $14.93 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.19 | 2021 | |
| Glaxosmithkline, LLC. | $14.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hina Kouser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.